Romil Patel

ORCID: 0000-0003-1291-1357
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • Cancer Treatment and Pharmacology
  • Chronic Myeloid Leukemia Treatments
  • Cardiac Arrhythmias and Treatments
  • Single-cell and spatial transcriptomics
  • Atrial Fibrillation Management and Outcomes
  • Peptidase Inhibition and Analysis
  • Semiconductor materials and devices
  • Integrated Circuits and Semiconductor Failure Analysis
  • Solar Thermal and Photovoltaic Systems
  • Viral Infectious Diseases and Gene Expression in Insects
  • Peripheral Neuropathies and Disorders
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Cancer therapeutics and mechanisms
  • CNS Lymphoma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Virus-based gene therapy research
  • Solar Energy Systems and Technologies

University of Chicago
2024

The University of Texas MD Anderson Cancer Center
2018-2024

NorthShore University HealthSystem
2024

The University of Texas Health Science Center at Houston
2021-2024

Evanston Hospital
2024

Ganpat University
2022-2024

Rowan University
2020-2024

Anderson University - South Carolina
2024

Sant Gadge Baba Amravati University
2023

Karnavati University
2023

53BP1 is a chromatin-associated protein that regulates the DNA damage response. In this study, we identify TPX2/Aurora A heterodimer, nominally considered mitotic kinase complex, as novel binding partner of 53BP1. We find plays previously unrecognized role in repair and replication fork stability by counteracting function. Loss TPX2 or Aurora compromises end resection, BRCA1 Rad51 recruitment, homologous recombination. Furthermore, loss causes deprotection stalled forks upon stress...

10.1083/jcb.201803003 article EN cc-by-nc-sa The Journal of Cell Biology 2019-01-02

Abstract Outcomes for diffuse large B-cell lymphoma (DLBCL) patients relapsing after autologous hematopoietic cell transplantation (auto-HCT) have been historically poor. We studied outcomes of such using data from 4 centers. Eligibility criteria included adult (age ≥18 years) with DLBCL experiencing disease relapse auto-HCT performed during 2006 to 2015. The time period was stratified into 2 eras (era 1, 2006-2010; era 2, 2011-2015). primary end point postrelapse overall survival (PR-OS)....

10.1182/bloodadvances.2019000102 article EN cc-by-nc-nd Blood Advances 2019-06-05

Key Points PR-OS of cHL patients has improved in recent years, likely due to incorporation novel therapies and more effective use allo-HCT. Future research should focus on earlier integration for with refractory disease improve outcomes further.

10.1182/bloodadvances.2019000736 article EN cc-by-nc-nd Blood Advances 2020-01-03

Patients with multiple myeloma t(11;14) have been considered to standard-risk disease. However, several recent reports shown contradictory results. We identified 95 patients on FISH studies, who underwent upfront autologous hematopoietic stem cell transplant (auto-HCT) at our center. compared their outcome a group of had diploid cytogenetics by both conventional (CC) and (n = 287).To reduce the bias between groups, we performed 1:1 propensity score matching technique for analysis. A total...

10.1158/1078-0432.ccr-19-0706 article EN Clinical Cancer Research 2019-09-03

Chimeric antigen receptor T-cell (CAR-T) therapy, despite being a potentially curative therapy in relapsed or refractory (RR) large B-cell lymphoma (LBCL), remains underutilized older patients due to limited clinical data. We therefore studied the safety and efficacy of CAR-T with RR LBCL real-world setting. Patients aged ≥65 years LBCL, treated anti-CD19 at 7 US institutions were included this multicenter, retrospective, observational study. In total, 226 included. Median age infusion was...

10.1002/ajh.27381 article EN American Journal of Hematology 2024-06-04

Introduction: Immune checkpoint inhibitors (ICI), such as pembrolizumab, are an effective immunotherapy for several malignancies, however, have been associated with adverse events including myocarditis and accelerated atherosclerosis. ICI is a mortality rate of up to 33%. This case reports patient on pembrolizumab atypical presentation. Case presentation: A 75-year-old female past medical history significant lung cancer myasthenia gravis presented the hospital dyspnea mild, intermittent...

10.1161/circ.150.suppl_1.4144526 article EN Circulation 2024-11-11

Patients with periodontitis are significantly more likely to have undetected diabetes mellitus (DM). Self‑monitoring devices like glucometers provide a simple method for rapid monitoring of the glucose level in blood by utilizing sample from finger, but this requires puncturing obtain blood. Bleeding gingival sulcus, obtained during oral hygiene examination, can be utilized screening DM patients. Therefore, study was performed aim determining efficacy crevicular as non-invasive patients,...

10.7759/cureus.39444 article EN Cureus 2023-05-24

In this retrospective analysis, we evaluated the impact of age on outcome patients with multiple myeloma who received an autologous hematopoietic stem cell transplantation (auto-HCT) at our institution. A total 1128 were divided into older (>70 years; 182 [16%]) and younger (≤70 946 [84%]) groups. Compared cohort, had a higher International Staging System (ISS) stage (ISS-II, 57 [31%] versus 215 [23%]; ISS-III, 52 [28%] 211 [22%]; P = .01), use reduced-dose melphalan as conditioning regimen...

10.1016/j.bbmt.2019.11.028 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2019-11-29

The cell of origin (COO) classification into germinal center B (GCB) and non-GCB types has been shown to predict survival outcomes in newly diagnosed diffuse large lymphoma (DLBCL). In the relapsed/refractory (R/R) setting, there is building evidence that COO does not prognosis after high-dose chemotherapy autologous stem transplantation (auto-SCT). present analysis aimed compare based on R/R DLBCL patients who underwent auto-SCT. This retrospective study included adult with auto-SCT at MD...

10.1016/j.jtct.2021.02.009 article EN cc-by-nc-nd Transplantation and Cellular Therapy 2021-02-16

Background: Bruton tyrosine kinase inhibitors, such as ibrutinib, are medications that actively used for Chronic Lymphocytic Leukemia (CLL) and several lymphomas. They work by inhibiting Bruton’s therefore affecting B cell proliferation. Ibrutinib itself is associated with multiple cardiotoxicities including atrial fibrillation, ventricular arrhythmias, heart failure, bleeding. There well-established studies show the incidence of fibrillation ibrutinib therapy. However, only a few reports an...

10.52768/cardiology/1007 article EN SciBase cardiology. 2024-02-27

Solar cooker with different collector like evacuated tubes collector, parabolic trough flat plate and Scheffler reflector etc are generally used for the cooking food SHSMs or PCMs. Present research article, combined heat storage material (one SHSM one PCM) late-evening has been experimentally investigated. One is placed within inner pot of a solar cooker, while another outer cooker. Six combinations formed from various (sand, pebbles, iron pieces) PCM (acetamide). During daytime, absorbed...

10.17576/jkukm-2024-36(4)-16 article EN cc-by Jurnal Kejuruteraan 2024-07-30
Coming Soon ...